ASX Share rice
Tue 04 Aug 2020 - 03:34:pm (Sydney)

MDC Share Price

MEDLAB CLINICAL LIMITEDMDCPharmaceuticals, Biotechnology & Life Sciences

MDC Company Information

Name:

Medlab Clinical Limited

Sector:

Healthcare

Industry:

Biotechnology

GIC Industry:

Biotechnology

GIC Sub Industry:

Biotechnology

Address:

66 McCauley Street Alexandria NSW Australia 2015

Phone:

61 2 8188 0311

MD, CEO & Director:

Dr. Sean Michael Hall

CFO & Company Sec.:

Mr. Alan Dworkin

Director of Medical Research:

Dr. Luis Vitetta BSc(Hons), Grad Dip, Ph.D., Grad Dip Nutr

Director of Science:

Dr. David A. Rutolo

Director of Commercial Operations:

Mr. Paul Vilner

Company Overview:

Medlab Clinical Limited engages in the sale of nutraceutical products, and pharmaceutical research and commercialization in Australia. The company develops bio-therapeutics for bio-therapeutics for chronic kidney diseases, pre-diabetes/obesity, depression, and musculoskeletal muscle loss associated with ageing. It also provides nutraceuticals for anti-inflammatory, cardiovascular support, endocrine support, gastrointestinal support, immunological support, infants and toddlers, metabolic support, musculoskeletal support, neurological support, sports performance, urogenital support, and weight management, as well as for men, pregnancy, seniors, teenagers, and women support. Medlab Clinical Limited was founded in 2012 and is based in Alexandria, Australia.

MDC Share Price Information

Shares Issued:

269.21M

Market Capitalisation:

$37.69M

Revenue (TTM):

$4.87M

Revenue Per Share (TTM):

$0.02

Earnings per Share:

$-0.039

Profit Margin:

-2.3641

Operating Margin (TTM):

$-2.40

Return On Assets (TTM):

$-0.37

Return On Equity (TTM):

$-0.75

Quarterly Revenue Growth (YOY):

-0.181

Gross Profit(TTM):

$2.37M

Diluted Earnings Per Share (TTM):

$-0.054

MDC CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-340,323

Change To Liabilities:

$1.68M

Total Cashflow From Investing Activities:

$-340,323

Net Borrowings:

$472.27K

Net Income:

$-8,090,937

Total Cash From Operating Activities:

$-10,316,577

Depreciation:

$147.49K

Change To Inventory:

$-1,053,918

Change To Account Receivables:

$-1,757,886

Capital Expenditures:

$340.32K

MDC Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-8,174,096

Net Income:

$-8,090,937

Gross Profit:

$2.37M

Operating Income:

$-10,749,108

Other Operating Expenses:

$1.15M

Interest Expense:

$79.77K

Total Revenue:

$5.43M

Total Operating Expenses:

$13.12M

Cost Of Revenue:

$3.06M

MDC Balance Sheet

Balance Sheet Date:

2019-06-30

Total Liabilities:

$5.21M

Total Stockholder Equity:

$15.05M

Other Current Liabilities:

$81.43K

Total Assets:

$20.20M

Common Stock:

$41.62M

Other Current Assets:

$1.62M

Retained Earnings:

$-26,643,581

Other Liabilities:

$228.24K

Other Assets:

$482.85K

Cash:

$11.44M

Total Current Liabilities:

$4.98M

Short-Term Debt:

$0.97M

Property - Plant & Equipment:

$631.70K

Net Tangible Assets:

$15.05M

Total Current Assets:

$19.09M

Net Receivables:

$1.82M

Short-Term Investments:

$1.11M

Inventory:

$2.22M

Accounts Payable:

$2.55M

Non Currrent Assets (Other):

$482.85K

Short-Term Investments:

$1.11

Non Current Liabilities Total:

$228.24K

MDC Share Price History

MDC News

21 Apr, 2020
Medlab Clinical Limited (ASX:MDC) shareholders should be happy to see the share price up 13% in the last month. But...
20 Jan, 2020
Sean Hall is the CEO of Medlab Clinical Limited (ASX:MDC). First, this article will compare CEO compensation with...
21 Oct, 2019
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
05 Sep, 2019
By buying an index fund, you can roughly match the market return with ease. But if you choose individual stocks with...